⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10666 | 1.00 | — | — | |
| SCHEMBL196185 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL443105 | 0.84 | BTN3A1 (0.50) | — | |
| SCHEMBL9578998 | 0.78 | TSHR (0.33) | — | |
| SCHEMBL25227766 | 0.74 | — | — | |
| SCHEMBL28186956 | 0.73 | — | — | |
| SCHEMBL4623680 | 0.73 | KMT2A (0.50) | — | |
| SCHEMBL15655770 | 0.73 | KMT2A (0.50) | — | |
| SCHEMBL4671195 | 0.73 | KMT2A (0.50) | — | |
| SCHEMBL1301055 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3601205-B1 | PROCESS FOR THE PREPARATION OF ALPHA, BETA UNSATURATED ALDEHYDES BY OXIDATION OF ALCOHOLS IN THE PRESENCE OF A LIQUID PHASE | BASF SE (DE) | 2025-12-24 | — | — | EP | disclosed |
| CN-117603025-A | Process for preparing alpha, beta unsaturated aldehydes by oxidizing alcohols in the presence of a liquid phase | 巴斯夫欧洲公司 | 2024-02-27 | — | — | CN | disclosed |
| CN-110418779-B | Process for preparing alpha, beta unsaturated aldehydes by oxidizing alcohols in the presence of a liquid phase | 巴斯夫欧洲公司 | 2023-12-15 | — | — | CN | disclosed |
| US-20230165839-A1 | MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE | ELIXIR MEDICAL CORPORATION (US) | 2023-06-01 | — | — | US | disclosed |
| US-20230165839-A1 | MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE | ELIXIR MEDICAL CORPORATION (US) | 2023-06-01 | — | — | US | disclosed |
| US-11332426-B2 | Method of preparing trisubstituted ethylene compounds | TRUSTEES OF BOSTON COLLEGE (US) | 2022-05-17 | — | — | US | disclosed |
| US-11111197-B2 | Process for the preparation of alpha, beta unsaturated aldehydes by oxidation of alcohols in the presence of a liquid phase | BASF SE (DE) | 2021-09-07 | — | — | US | disclosed |
| US-20210008040-A1 | MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE | ELIXIR MEDICAL CORPORATION (US) | 2021-01-14 | — | — | US | disclosed |
| US-10875821-B2 | Process for the preparation of alpha, beta unsaturated aldehydes by oxidation of alcohols in the presence of a liquid phase | BASF SE | 2020-12-29 | — | — | US | disclosed |
| US-20200392060-A1 | PROCESS FOR THE PREPARATION OF ALPHA, BETA UNSATURATED ALDEHYDES BY OXIDATION OF ALCOHOLS IN THE PRESENCE OF A LIQUID PHASE | BASF SE (DE) | 2020-12-17 | — | — | US | disclosed |
| US-9149470-B2 | Macrocyclic lactone compounds and methods for their use | ELIXIR MEDICAL CORPORATION (US) | 2015-10-06 | — | — | US | disclosed |
| US-8263644-B2 | Cytotoxic xanthone compounds | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-09-11 | — | — | US | disclosed |
| US-20120071500-A1 | MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE | ELIXIR MEDICAL CORPORATION (US) | 2012-03-22 | — | — | US | disclosed |
| US-20120071500-A1 | MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE | ELIXIR MEDICAL CORPORATION (US) | 2012-03-22 | — | — | US | disclosed |
| US-8088789-B2 | Administering hemiketal ring and seco-macrocyclic lactones; immunosuppressive, anti-proliferative, anti-fungal and anti-tumor | ELIXIR MEDICAL CORPORATION (US) | 2012-01-03 | — | — | US | disclosed |
| US-8088789-B2 | Administering hemiketal ring and seco-macrocyclic lactones; immunosuppressive, anti-proliferative, anti-fungal and anti-tumor | ELIXIR MEDICAL CORPORATION (US) | 2012-01-03 | — | — | US | disclosed |
| US-20100311826-A1 | CYTOTOXIC XANTHONE COMPOUNDS | BRISTOL-MYERS SQUIBB COMPANY | 2010-12-09 | — | — | US | disclosed |
| US-20080234309-A1 | MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE | ELIXIR MEDICAL CORPORATION (US) | 2008-09-25 | — | — | US | disclosed |
| US-20080234309-A1 | MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE | ELIXIR MEDICAL CORPORATION (US) | 2008-09-25 | — | — | US | disclosed |
| EP-1546134-B1 | PIPERAZINE SUBSTITUTED ARYL BENZODIAZEPINES | LILLY CO ELI (US) | 2007-05-02 | — | — | EP | disclosed |